Larson Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.4K | Buy |
222
+23
| +12% | +$7.5K | ﹤0.01% | 940 |
|
|
2025
Q1 | $53.7K | Buy |
199
+87
| +78% | +$23.5K | ﹤0.01% | 993 |
|
|
2024
Q4 | $26.4K | Buy |
112
+73
| +187% | +$17.2K | ﹤0.01% | 1111 |
|
|
2024
Q3 | $10.7K | Buy |
39
+12
| +44% | +$3.3K | ﹤0.01% | 1450 |
|
|
2024
Q2 | $6.56K | Hold |
27
| – | – | ﹤0.01% | 1376 |
|
|
2024
Q1 | $4.04K | Buy |
+27
| New | +$4.04K | ﹤0.01% | 1234 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 1791 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1707 |
|